Preferred Networks (Preferred Networks)

Chiyoda City, Japan

Preferred Networks aims to transform the entire landscape of IoT using Deep Learning technologies, applying this technology to applications of significant industrial importance. PFN conducts research and development and commercialization centered on omics analysis, medical image analysis, and compound analysis. PFN advocates the use of Edge Heavy Computing to handle the enormous amounts of data generated by devices in a distributed and collaborative manner at the edge of the network, driving innovation in various fields, with a focus on three business areas: transportation, manufacturing, and bio/healthcare.

✓Source: HealthTech Alpha by Galen Growth

Shareable draft

Check out Preferred Networks (Preferred Networks) on @MedStartr Today #GeneralHealth #HealthManagement #AIML #Biotech #MedMo #MedStartrVentures

https://www.medstartr.ai/s/wywC6T8YGoY

Get Involved in Preferred Networks (Preferred Networks)

🏢Is this your company? Claim This Profile

Join MedStartr to verify with your work email and edit this profile

Company Info

Founded: 2014
Website: www.preferred.jp/ja

Disease Areas

General Health Health Management

Technologies

Deep LearningIoTAI/Machine LearningBiotechnology

🌐Website

MedStartr Engagement Score

The MedStartr Index is a reflection of how the crowds that come to MedStartr everyday to find healthcare innovations reacted. Calculated by our AI agent Fyggy based on algorithms we have been building since 2012 and over 100 different factors, the math is proprietary and complex. Suffice to say, it has been found to be highly correlative with early stage company growth. What you see here is the public version. To learn more or to get deeper access to our predictive data on startup success for your fund or company, click here.

Comments

Comments from new members are shown once the company's team has approved them. Please follow the community rules.

Be the first to comment.

What do you think of Preferred Networks (Preferred Networks)?

A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.

Clinical Benefit Potential

The potential for a project to have a large and significant impact on medical care, treatment, or prevention.

Feasibility

The likelihood that this will provide benefit for patients / care givers and that the founders can execute on their vision and plan.

Innovativeness

The distinguishing features, concept, or technology that differentiates the entry compared to others that already exist and are in widespread use.

Fundability

The reviewers' beliefs that the idea is fundable or can make it to sustainability without outside investment.

Scalability

Some great ideas are destined to failure because they are too complex or too expensive. The reviewer should consider the likelihood that a project as explained, or perhaps with some tweaks, could possibly become a worldwide solution within a reasonable time frame.

Presentation Quality

How well the team presented the idea.

Submit anonymously — my name won't be shown to the team or on this profile

Your scores and comments are shown with your review on this company's profile.